1. Recent advances in use of silver nanoparticles as antimalarial agents
- Author
-
Serenella Medici, Avinash P. Ingle, Mahendra Rai, Carolina Alves dos Santos, Priti Paralikar, and Indarchand Gupta
- Subjects
0301 basic medicine ,Silver ,Plasmodium falciparum ,Metal Nanoparticles ,Pharmaceutical Science ,Drug resistance ,010501 environmental sciences ,Pharmacology ,01 natural sciences ,Antimalarials ,03 medical and health sciences ,Drug Delivery Systems ,Anopheles ,parasitic diseases ,medicine ,Animals ,Humans ,Antimalarial Agent ,0105 earth and related environmental sciences ,Traditional medicine ,biology ,medicine.disease ,biology.organism_classification ,Malaria ,Applications of nanotechnology ,030104 developmental biology ,Drug delivery ,Female ,Nanocarriers - Abstract
Malaria is one of the most common infectious diseases, which has become a great public health problem all over the world. Ineffectiveness of available antimalarial treatment is the main reason behind its menace. The failure of current treatment strategies is due to emergence of drug resistance in Plasmodium falciparum and drug toxicity in human beings. Therefore, the development of novel and effective antimalarial drugs is the need of the hour. Considering the huge biomedical applications of nanotechnology, it can be potentially used for the malarial treatment. Silver nanoparticles (AgNPs) have demonstrated significant activity against malarial parasite (P. falciparum) and vector (female Anopheles mosquito). It is believed that AgNPs will be a solution for the control of malaria. This review emphasizes the pros- and cons of existing antimalarial treatments and in depth discussion on application of AgNPs for treatment of malaria. The role of nanoparticles for site specific drug delivery and toxicological issues have also been discussed.
- Published
- 2017
- Full Text
- View/download PDF